2021-01-11,"Aileron Therapeutics Announces Completion of $35.9 Million Registered Direct Offering with Participation by New Fundamental Healthcare Investors Acorn Bioventures, BVF Partners, L.P. and Maven Investment Partners"
2021-01-06,Aileron Therapeutics Announces $35.9 Million Registered Direct Offering
2020-12-23,Medicenna vs Aileron: Which Penny Stock Could Surge Over 200%?
2020-12-21,Aileron Therapeutics Provides Business Update and Outlines 2021 Strategic Priorities
2020-12-14,New Strong Sell Stocks for December 14th
2020-12-01,New Strong Sell Stocks for December 1st
2020-11-29,"Is Aileron Therapeutics, Inc. (ALRN) A Good Stock To Buy?"
2020-11-24,New Strong Sell Stocks for November 24th
2020-11-19,New Strong Sell Stocks for November 19th
2020-11-12,Aileron Therapeutics Reports Third Quarter 2020 Financial Results and Business Highlights
2020-10-24,Aileron Therapeutics Announces Proof-of-Concept Clinical Data from Ongoing ALRN-6924 Phase 1b Trial Presented in Late-Breaking Presentation at the EORTC-NCI-AACR Annual Symposium
2020-10-20,Aileron Therapeutics to Host Conference Call to Discuss Results from Phase 1b Proof-of-Concept Study of Chemoprotective Therapy ALRN-6924 Being Presented at EORTC-NCI-AACR Annual Symposium
2020-10-13,Aileron Therapeutics (ALRN) in Focus: Stock Moves 6.5% Higher
2020-10-12,Aileron Therapeutics Announces Proof-of-Concept Data for ALRN-6924 to be Featured in Late-Breaking Presentation at EORTC-NCI-AACR Annual Symposium
2020-09-21,Aileron Therapeutics Announces Common Stock Purchase Agreement for up to $15 Million with Lincoln Park Capital
2020-09-10,Aileron Therapeutics to Present at Upcoming H.C. Wainwright Virtual Global Investment Conference
2020-08-25,"The Zacks Analyst Blog Highlights: Emergent Biosolutions, Horizon, Novavax, Celldex and Aileron Therapeutics"
2020-08-05,Aileron Therapeutics Reports Second Quarter 2020 Financial Results  and Provides Business Update
2020-08-04,3 Strong Buy Penny Stocks That Could Go Boom
2020-08-03,Aileron Therapeutics to Present at Two Upcoming Investor Conferences  in August
2020-08-03,Aileron Therapeutics Announces Completion of Enrollment in Dose Optimization Expansion Cohort of Proof-of-Concept Phase 1b Study of ALRN-6924
2020-06-29,Aileron Therapeutics Initiates Enrollment in Schedule Optimization Part of Phase 1b/2 Study of ALRN-6924 as a Chemoprotection Agent in Small Cell Lung Cancer (SCLC) Patients Being Treated with Topotecan
2020-06-12,Largest Insider Trades of the Week
2020-06-10,Aileron Therapeutics Announces Closing of Public Offering of Common Stock and Exercise of Option to Purchase Additional Shares
2020-06-04,Aileron Therapeutics Announces Pricing of Public Offering of Common Stock
2020-06-03,Aileron Therapeutics Announces Proposed Public Offering of Common Stock
2020-06-02,"The Zacks Analyst Blog Highlights: Aileron Therapeutics, Energy Focus, MicroVision, Mersana Therapeutics and CymaBay Therapeutics"
2020-06-02,"The Daily Biotech Pulse: FDA Nod For Roche's Combo Therapy In Liver Cancer, Allena Rips Higher, Pfizer To Invest Up To $500M In Biotechs"
2020-06-01,5 Top Stocks Up 100%+ in May With More Room to Run
2020-06-01,Aileron Therapeutics Announces Positive Interim Results from Phase 1b/2 Clinical Trial of ALRN-6924 for the Prevention of Topotecan-induced Toxicities During Treatment for Small Cell Lung Cancer
2020-05-27,Aileron Therapeutics Announces Initiation of Expansion Cohort and First Patient Enrolled into Expansion Cohort of Phase 1b/2 Study of ALRN-6924 as a Chemoprotection Agent
2020-05-11,Aileron Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
2020-04-22,Aileron Therapeutics Announces Plans to Release Interim Results from its Phase 1b/2 Myelopreservation Study in Mid-2020
2020-03-30,Aileron Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
2019-12-20,"Hedge Fund Sentiment Is Unchanged On Aileron Therapeutics, Inc. (ALRN)"
2019-12-19,"Are Insiders Buying Aileron Therapeutics, Inc. (NASDAQ:ALRN) Stock?"
2019-12-18,Aileron Therapeutics Announces the Promotion of Richard J. Wanstall to Chief Financial Officer and Treasurer
2019-11-07,Aileron Therapeutics Reports Third Quarter 2019 Results
2019-10-31,Aileron Therapeutics to Report Third Quarter 2019 Financial Results on November 7th
2019-10-29,Aileron Therapeutics Announces Positive Nonclinical Myelopreservation Results for ALRN-6924 at the 2019 AACR-NCI-EORTC Conference
2019-10-21,Aileron to Present Nonclinical Myelopreservation Data for ALRN-6924 at the 2019 AACR-NCI-EORTC Conference on October 29th
2019-10-16,Aileron Therapeutics Announces the Initiation of Patient Treatment in its First Clinical Ph1b/2 Trial of ALRN-6924 as a Myelopreservation Agent
2019-09-28,Aileron Presents Positive Interim Phase 2a Data for ALRN-6924 in Combination with Pfizers Palbociclib at the 2019 Congress of the European Society for Medical Oncology
2019-09-24,Aileron to Present Interim Phase 2a Clinical Data for ALRN-6924 in Combination with Pfizers IBRANCE® (palbociclib) in Patients with MDM2-Amplified Cancers at the 2019 Congress of the European Society for Medical Oncology
2019-09-19,"How Much Money Does Aileron Therapeutics, Inc. (NASDAQ:ALRN) Have Left?"
2019-09-09,Aileron Therapeutics Announces Management Change
2019-09-03,Aileron Therapeutics to Present at the H.C. Wainwright 21st Annual Global Investment Conference in New York
2019-08-06,Aileron Therapeutics Reports Second Quarter 2019 Financial Results
2019-07-30,Aileron Therapeutics to Present at the Canaccord Genuity 39th Annual Growth Conference
2019-07-30,"Aileron Therapeutics to Report Second Quarter 2019 Financial Results on August 6, 2019"
2019-07-17,"What Kind Of Shareholders Own Aileron Therapeutics, Inc. (NASDAQ:ALRN)?"
2019-06-27,Aileron Therapeutics Announces FDA Acceptance of IND for ALRN-6924 as a Myelopreservation Agent in Patients with p53-mutant Cancer Treated with Chemotherapy
2019-06-24,Aileron Therapeutics Strengthens Board of Directors with Appointments of William T. McKee and Josef H. von Rickenbach
2019-05-30,Aileron Therapeutics to Present at the Jefferies 2019 Healthcare Conference
2019-05-08,Aileron Therapeutics Reports First Quarter 2019 Financial Results
2019-05-01,Aileron Therapeutics to Report First Quarter 2019 Financial Results on May 8
2019-04-03,Aileron Therapeutics Completes $26M Private Placement
2019-03-29,Aileron Therapeutics Announces Pricing of $26M Private Placement
2019-03-04,Aileron Therapeutics Appoints Kathryn Gregory as Chief Business Officer
2019-02-01,4 Healthcare Stocks Looking To Start February Off Strong
2019-01-29,"Aileron Therapeutics, Inc. (ALRN) Upgraded to Strong Buy: Here's Why"
2019-01-16,Aileron Therapeutics Commences Enrollment in a Phase 2a Expansion Cohort for ALRN-6924 in Combination with Pfizers IBRANCE® (palbociclib) in Patients with MDM2-Amplified Cancers
2018-12-21,"Could The Aileron Therapeutics, Inc. (NASDAQ:ALRN) Ownership Structure Tell Us Something Useful?"
2018-12-04,"Aileron Presents Interim ALRN-6924 Data from PTCL, MDS, and AML Clinical Trials at the 60th Annual American Society of Hematology Meeting"
2018-11-28,Aileron Inks Collaboration Deal With Pfizer for Cancer Combo
2018-11-27,Aileron Enters Clinical Trial Collaboration with Pfizer to Evaluate ALRN-6924 in Combination with IBRANCE® (palbociclib) in MDM2-Amplified Cancers
2018-11-19,"Recent Analysis Shows Arcimoto, ADOMANI, Lipocine, Aileron Therapeutics, Allena Pharmaceuticals, and Perma-Fix Environmental Services Market Influences  Renewed Outlook, Key Drivers of Growth"
2018-11-07,Aileron Therapeutics Reports Third Quarter 2018 Financial Results
2018-11-05,"Aileron Therapeutics Appoints Vojislav Vukovic, MD, PhD, as Chief Medical Officer"
2018-11-01,Aileron Therapeutics Announces Clinical Trial Collaboration with Dana-Farber/Boston Childrens Cancer and Blood Disorders Center
2018-10-30,"Aileron Therapeutics to Report Third Quarter 2018 Financial Results on November 7, 2018"
2018-10-19,Aileron Announces Poster Presentations at Two Scientific Conferences in November
2018-09-06,Aileron Therapeutics Announces the Appointment of Dr. Manuel Aivado as Chief Executive Officer
2018-08-07,Aileron Therapeutics Reports Second Quarter 2018 Financial Results
2018-08-02,Aileron Therapeutics to Present at the Canaccord Genuity 38th Annual Growth Conference
2018-07-31,"Aileron Therapeutics to Report Second Quarter 2018 Financial Results on August 7, 2018"
2018-05-29,Aileron Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference
2018-05-22,Aileron Therapeutics Announces Publication of ALRN-6924 Nonclinical Data in T-cell Lymphomas by Researchers at Dana-Farber Cancer Institute
2018-05-15,Aileron Therapeutics Announces Changes to Management
2018-05-09,Aileron Therapeutics Reports First Quarter 2018 Financial Results
2018-04-11,Aileron Therapeutics Announces Publication by Researchers at Albert Einstein College of Medicine of ALRN-6924 Nonclinical Data in Acute Myeloid Leukemia
2018-04-02,Aileron Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
2018-03-28,Aileron Therapeutics Announces Expansion of Scientific Advisory Board
2018-03-19,Aileron Therapeutics Appoints Jeffrey A. Bailey to its Board of Directors
2017-12-11,Aileron Therapeutics Presents New Data on ALRN-6924 in Oral Presentations at 2017 American Society of Hematology Meeting
2017-11-09,Aileron Therapeutics Reports Third Quarter 2017 Financial Results
2017-11-01,Aileron Therapeutics Announces Oral Presentations on Lead Product Candidate ALRN-6924 at the 59th American Society of Hematology Annual Meeting
2017-10-05,Boston biotech developing obesity drug pulls down $120M in IPO
2017-09-19,"Aileron Therapeutics Added to the Russell 2000, Russell 3000 and Russell Microcap Indexes"
2017-08-24,Aileron Therapeutics Announces Presentation of Preclinical Data with ALRN-6924 at the International Society of Experimental Hematology Annual Scientific Meeting
2017-08-10,Aileron Therapeutics Reports Second Quarter 2017 Financial Results
2017-08-03,Aileron Therapeutics to Present at Canaccord Genuity 37th Annual Growth Conference
2017-07-19,"[$$] Novartis, Glaxo and Lilly Bigly Back New Biotech"
2017-07-07,The Largest Insider Trades of the Week
2017-07-03,Here's the Latest on Four New Biotech IPOs
2017-06-28,Aileron Therapeutics Announces Pricing of Initial Public Offering
